Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5183013
Max Phase: Preclinical
Molecular Formula: C46H79NO13
Molecular Weight: 854.13
Associated Items:
ID: ALA5183013
Max Phase: Preclinical
Molecular Formula: C46H79NO13
Molecular Weight: 854.13
Associated Items:
Canonical SMILES: CCCCCCCCC/C=C\CCCCCCC(=O)N[C@H]1[C@H](OC(=O)CCC(=O)O)O[C@H](CO)[C@@H](OC(=O)CCC(=O)O)[C@@H]1OC(=O)CCCCCCCCCCCCC
Standard InChI: InChI=1S/C46H79NO13/c1-3-5-7-9-11-13-15-16-17-18-20-21-23-25-27-29-37(49)47-43-45(59-40(54)30-28-26-24-22-19-14-12-10-8-6-4-2)44(58-41(55)33-31-38(50)51)36(35-48)57-46(43)60-42(56)34-32-39(52)53/h17-18,36,43-46,48H,3-16,19-35H2,1-2H3,(H,47,49)(H,50,51)(H,52,53)/b18-17-/t36-,43-,44-,45-,46+/m1/s1
Standard InChI Key: ILJAYYTXBFCTGR-RJVZBCKZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 854.13 | Molecular Weight (Monoisotopic): 853.5551 | AlogP: 9.02 | #Rotatable Bonds: 38 |
Polar Surface Area: 212.06 | Molecular Species: ACID | HBA: 11 | HBD: 4 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.36 | CX Basic pKa: | CX LogP: 10.35 | CX LogD: 3.71 |
Aromatic Rings: 0 | Heavy Atoms: 60 | QED Weighted: 0.02 | Np Likeness Score: 0.68 |
1. Zhang Y, Liang X, Bao X, Xiao W, Chen G.. (2022) Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective., 235 [PMID:35307617] [10.1016/j.ejmech.2022.114291] |
Source(1):